,III

Naoki Hayase1, Rohit R Chari, Alef A C Dos Santos

  • 1Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland, USA.

Shock (Augusta, Ga.)
|July 15, 2025
PubMed
概括

在败血症发作后持续输注抗素III (AT) 改善了小鼠的生存率. 这种延迟的,连续的AT输送效果优于玻尿酸注射,这表明了败血症的新治疗方法.